FdaApplication

ANDA 203455

Back to search

Identifiers

Properties

PropertyValue
applicant_nameINVAGEN PHARMACEUTICALS INC
application_typeANDA
approval_date2015-12-18

Products (3)

ProductActive ingredientStrengthDosage form
NADOLOLNADOLOL20MGTABLET;ORAL
NADOLOLNADOLOL40MGTABLET;ORAL
NADOLOLNADOLOL80MGTABLET;ORAL

3 products